Clinical trial · Observational
Clinical Validation of Cervical Cancer Screening Methods
Clinical Validation of Cervical Cancer Screening Methods in St. Petersburg, Russia
NCT04783649CI-TRIAL-00050508unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This single-institution cross-sectional non-inferiority validation study evaluates alternative techniques and tests for primary cervical cancer screening programs in Russia, particularly: local cytology staining techniques, local HPV tests.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
| Cervical Dysplasia | Cervical Intraepithelial Neoplasia | ALIAS | 0.90 |
| Human Papilloma Virus | — | UNRESOLVED | — |
Interventions
Interventions (5)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Colposcopy | Diagnostic Test | — | UNRESOLVED |
| Local cytological test (H&E stain) | Diagnostic Test | — | UNRESOLVED |
| Local HPV test | Diagnostic Test | — | UNRESOLVED |
| Papanicolaou cytological test | Diagnostic Test | — | UNRESOLVED |
| Validated HPV DNA Test | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- High risk group
- description
- Women in the age group between 25 and 65 years old without prior history of malignancy referred to colposcopy
- interventionNames
- Diagnostic Test: Papanicolaou cytological test
- Diagnostic Test: Local cytological test (H&E stain)
- Diagnostic Test: Validated HPV DNA Test
- Diagnostic Test: Local HPV test
- Diagnostic Test: Colposcopy
- label
- Population sample
- description
- A population sample of women in the age group between 25 and 65 years old from several primary healthcare facilities to primary cervical screening
- interventionNames
- Diagnostic Test: Papanicolaou cytological test
- Diagnostic Test: Local cytological test (H&E stain)
- Diagnostic Test: Validated HPV DNA Test
- Diagnostic Test: Local HPV test
Primary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: Age between 25 and 65 years old Referral to colposcopy or to a primary screening test Signed informed consent Exclusion Criteria: Prior history of malignancy or cervical dysplasia Prior history of cervical dysplasia
References
Publications (0)
Data not yet available
No reference posted for this study.